OncoNano Medicine
Southlake, Texas, United States · Biotechnology, Health Care, Medical
OncoNano is harnessing the power of nanotechnology to unlock a new era of targeted therapeutics. Our ON-BOARD™ polymeric micelle platform exploits the highly acidic tumor microenvironment, a byproduct of cancer metabolism, to precisely deliver therapeutic payloads directly to the tumor site. OncoNano’s product candidates are designed to improve the pharmacokinetic and pharmacodynamic properties of
Key facts
- Headquarters
- Southlake, Texas, United States
- Employees
- 23
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- https://www.onconano.com
- Company page
Recent activity at OncoNano Medicine
- : OncoNano Medicine and Gilead Sciences Enter Research Collaboration for ON-BOARD™ Technology on Gilead’s Drug Candidate.
- : OncoNano Appoints Brent Sorrells as Chief Operating Officer
- : OncoNano Medicine
- : OncoNano Medicine Appoints Dr. Kartik Krishnan as CEO and Dr. Melissa Paoloni as COO
- : OncoNano Medicine Appoints Dr. Kartik Krishnan as Chief Executive Officer and Dr. Melissa Paoloni as Executive Vice President and Chief Operating Officer
- : OncoNano Medicine Announces Promotion of Kartik Krishnan, MD, PhD, to President and Head of Research & Development
- : OncoNano Medicine, Inc.
- : Onconano Medicine Raises ~$50 Million In Series B Financing
- : OncoNano Medicine, Inc.
- : OncoNano Medicine, Inc.
OncoNano Medicine funding history
| Date | Round | Amount |
|---|---|---|
| Jun 2025 | Venture | $12.7M |
| Jun 2021 | Venture | $49.1M |
| Jun 2021 | Series B | $50.0M |
| Mar 2021 | Venture | $26.4M |
| Oct 2020 | Venture | $49.1M |
Leadership
- Brent Sorrells, Chief Operating Officer
- Kartik Krishnan, Chief Executive Officer
- Kartik Krishnan, Chief Executive Officer
- Melissa Paoloni, Chief Operating Officer
- Matthew Head, Executive Officer
Verified email and direct lines for OncoNano Medicine’s decision-makers are on Fundz. See plans
Employee benefit plans
OncoNano Medicine files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
OncoNano Medicine in the news
Companies similar to OncoNano Medicine
- Imugene · Biotechnology, Health Care, Medical, Therapeutics
- NuCana · Biotechnology, Health Care, Medical, Therapeutics
- Aethlon Medical · Biotechnology, Health Care, Medical, Therapeutics
- NRx Pharmaceuticals · Biotechnology, Health Care, Medical, Therapeutics
- Aerska · Biotechnology, Health Care, Medical, Therapeutics
About OncoNano Medicine: questions and answers
What does OncoNano Medicine do?
OncoNano is harnessing the power of nanotechnology to unlock a new era of targeted therapeutics. Our ON-BOARD™ polymeric micelle platform exploits the highly acidic tumor microenvironment, a byproduct of cancer metabolism, to precisely deliver therapeutic payloads directly to the tumor site. OncoNano’s product candidates are designed to improve the pharmacokinetic and pharmacodynamic properties of
Where is OncoNano Medicine headquartered?
OncoNano Medicine is headquartered in Southlake, Texas, United States.
How many employees does OncoNano Medicine have?
OncoNano Medicine has about 23 employees.
Has OncoNano Medicine raised funding?
Yes. Fundz has recorded 5 funding events for OncoNano Medicine. The most recent, $12.7M, was in Jun 2025.
Who leads OncoNano Medicine?
Kartik Krishnan is a Chief Executive Officer at OncoNano Medicine.
What is the latest news on OncoNano Medicine?
On Jan 06, 2026, OncoNano Medicine and Gilead Sciences Enter Research Collaboration for ON-BOARD™ Technology on Gilead’s Drug Candidate.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy